Discovering Incidental Thyroid Disease by Imaging Studies  by Lin, Jen-Der
Journal of Medical Ultrasound (2015) 23, 11e13Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.jmu-onl ine.comEDITORIALDiscovering Incidental Thyroid Disease by
Imaging StudiesIt is not surprising that there is a high incidence of inci-
dental thyroid disease (ITD) discovery during carotid color
Doppler ultrasound examination. However, ITD prevalence
is variable. As reported in this issue and in a previous study,
21.8e51% of ITD cases were diagnosed during neck ultra-
sound for carotid artery examination [1]. ITD includes
diffuse thyroid and nodular thyroid disease. Most ITD pa-
tients were euthyroid. Patients with hyperthyroidism or
hypothyroidism, such as in Graves’ disease or Hashimoto
thyroiditis, may coexist with ITDs such as incidental thyroid
carcinoma [2]. ITD may be diagnosed during an examination
for nonthyroid disease by different imaging studies. Thyroid
diseases are detected by head and neck ultrasound, chest
radiography, computed tomography (CT), magnetic reso-
nance imaging, fluoro-18-deoxyglucose positron emission
tomography CT (PET-CT), and other examinations [3]. The
incidence of thyroid cancer, especially papillary thyroid
carcinoma, has increased in recent decades [4]. Part of the
reason may be due to an increase in the detection rates of
ITD during examinations. In addition, ITD may be diagnosed
during surgery or during a final histopathological examina-
tion for head and neck surgery [5].
Because of the increased ITD incidence, a differential
diagnosis between benign and malignant lesions is war-
ranted. It is not unusual for endocrinologists to follow-up
and examine patients who have ITD. History and physical
examination may reveal thyroid dysfunction, and family
history of thyroid cancer or radiation exposure is an
important indicator. Functional studies with free T4,
thyroid-stimulating hormone, antithyroid peroxidase anti-
body, and thyroid ultrasonography are the first-line exam-
inations. For diffused thyroid disease in ITD, many cases
may be diagnosed as simple goiter, Hashimoto thyroiditis,
autoimmune thyroid disease, or Graves’ disease. A recent
series by Rho and Kim [6] showed that thyroid ultrasound
and neck CT have similar diagnostic values for differenti-
ating incidental diffuse thyroid disease presenting as ITDConflicts of interest: The author declares no conflicts of
interest.
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nodular thyroid disease is diagnosed by thyroid ultrasound.
High-resolution thyroid ultrasound can illustrate very small
thyroid nodules measuring <5 mm. Thyroid nodules pre-
senting with hypoechogenicity, microcalcification, irregular
margins, or perinodular and intranodular hypervascularity
usually suggest malignancy. The next step after thyroid
ultrasound for the patient is fine-needle aspiration cytology
(FNAC) from a thyroid nodule suspicious for malignancy.
In a previous study, a total of 8806 patients underwent
11,618 thyroid ultrasound examinations to analyze the risk
of thyroid cancer associated with thyroid nodules identified
on ultrasound imaging [7]. There are three important ul-
trasound nodule characteristics that were associated with
the risk of thyroid cancer: microcalcifications, size >2 cm,
and an entirely solid composition (odds ratios, 8.1, 3.6, and
4.0, respectively). In clinical practice, patients with hypo-
echoic nodules, intranodular vascularization detected at
Doppler ultrasound, nodules with irregular margins,
increased volume, and microcalcifications are always sug-
gested to undergo FNAC. Results of echo-guided FNAC or
fine-needle aspiration after ultrasonography without guid-
ance and the nature of the thyroid nodule (e.g., vascu-
larity, cystic content in a complex mass) are important
indicators for obtaining enough cells for interpretation. For
cases diagnosed as malignant, suspicious for malignancy, or
a follicular neoplasm, surgical intervention is indicated [8].
Previous studies have reported the frequency of incidental
papillary thyroid carcinoma to be 4.6e10% of operatively
treated benign thyroid diseases. Among these incidental
papillary thyroid carcinomas were 12% of patients with
Hashimoto thyroiditis and 40% with contralateral follicular
adenoma [2].
ITD or incidental thyroid cancer may present during neck
surgery for nonthyroid disease. One study reported that
thyroid nodules were identified in 159 of 217 patients
(73.3%) who underwent surgery for hyperparathyroidism
[9]. Among the 159 patients, four had papillary thyroid
carcinoma, including one with papillary thyroid micro-
carcinoma and one with Hu¨rthle cell carcinoma. ITD may beof Ultrasound in Medicine. Open access under CC BY-NC-ND license.
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head and neck cancer. For example, in another study, of
the 690 head and neck cancer patients evaluated, 234
(33.9%) had incidental thyroid lesions on ultrasonography
and 9.4% had thyroid cancer. Occasionally, papillary thyroid
carcinoma in the lymph nodes of patients with head and
neck cancer required radical neck dissection. Character-
istic findings of a thyroid origin were demonstrated by
follicular structure and thyroglobulin staining in immuno-
chemical studies [10].
To evaluate subsequent management and outcome of
the incidental thyroid cancer found during surgery for head
and neck squamous cell carcinoma, a retrospective review
of 2538 neck dissections was performed [11]. Twenty-nine
patients had an incidental pathologic finding of thyroid
cancer at surgery. Seven patients, all of whom are still
alive, received further treatment for their thyroid cancer:
two underwent completion thyroidectomy, two received
radioactive iodide 131I ablation, and three underwent both.
There was no clinical evidence of thyroid cancer recur-
rence, and no one died due to of thyroid cancer. These
results suggest that further management of incidental
thyroid cancer detected in patients receiving neck dissec-
tions for head and neck cancer is unnecessary.
Increased incidence of thyroid cancer in developed and
developing countries is well-known, most of which are
papillary thyroid carcinoma. An increased percentage of
papillary thyroid microcarcinoma with a tumor size 1.0 cm
has been reported [12]. Some of these cases are incidental
papillary thyroid microcarcinoma diagnosed during final
histopathologic studies after surgery. A systematic review
and meta-analysis of 21,329 person-years including 854
cases with incidental papillary thyroid microcarcinoma and
2669 cases of nonincidental papillary thyroid micro-
carcinoma showed that the recurrence rate in the inci-
dental group was significantly lower than that in the
nonincidental group [13]. The management protocol be-
tween these two groups is different, however.
Clinical features and presentations of incidental thy-
roid cancer depended on the examination tool. A large
series study of incidental thyroid cancer diagnosed from
focal thyroid incidentalomas using PET-CT showed that
approximately one third of focal thyroid uptakes were
malignant. The maximum standardized uptake value cut-
off useful in differentiating benign from malignant inci-
dentalomas varied from 4.8 to 7 [14]. Comparison of
incidental thyroid cancer detected by PET-CT with non-
PET-CT incidental thyroid cancer showed no significant
differences in clinicopathologic features except for age
and TNM staging. More incidental thyroid cancer than
nonincidental thyroid cancer patients were aged 45
years and there were more incidental thyroid cancer pa-
tients with TNM stage III/IV tumors [15]. A comparison of
other incidentally discovered thyroid cancer by
nonthyroid-related imaging with nonincidentally discov-
ered thyroid cancer studies that were nonspecific in PET-
CT imaging illustrated similar results. Patients with inci-
dental thyroid cancer tend to be older and have higher
TNM stage disease and are more likely to be male
compared with patients with nonincidental thyroid can-
cer. In addition, there does not appear to be a significant
difference in the size, pathology, or behavior of the tumorat presentation between these two groups [16]. The re-
sults of these studies suggest that incidental thyroid can-
cer detected by PET-CT should be treated in the same
manner as nonincidental thyroid cancer.
Incidental thyroid nodules have been found in approx-
imately 16% of chest CT scans, and more commonly in
women. Most incidentally found thyroid lesions are
benign, with an approximate 9e11% prevalence of malig-
nant lesions [17]. No CT feature is reliable for dis-
tinguishing benign from malignant thyroid nodules; in
addition, CT has been reported as unreliable in dis-
tinguishing simple cysts, complex cysts, and solid nodules.
CT underestimates the number of nodules compared with
ultrasonography, suggesting that ultrasonography is a
useful adjunctive test after incidental detection of a
thyroid nodule on CT. In conclusion, most ITD in imaging
studies are benign lesions. Otherwise, differential diag-
nosis and treatment would be the same as that for non-
incidental thyroid disorders.
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